Bausch Health Companies Inc sees a modest uptick in stock performance this week, but challenges remain.
Bausch Health Companies Inc (BHC.TO) has experienced a slight rebound in stock price this week, closing at C$8.23, up 3.03% on the day and 3.68% over the week. Despite the positive momentum, the stock is still down 17.64% year-to-date, reflecting ongoing challenges in the healthcare sector.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.06B
52W high
$11.08
52W low
$6.10
1W change
+3.68%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC · as of Sep 17, 2026
Wall Street analysts forecast BHC stock price to fall 14.2% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-14.2% Upside
Current Price
C$8.17
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
46.3%
Annualized
90-Day Vol
66.6%
Annualized
Trend (90d)
+36.5%
Annualized drift
90d Mean
C$9.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.53 | C$7.27 – C$10.01 |
| 60 trading days | C$8.91 | C$7.11 – C$11.17 |
| 90 trading days | C$9.31 | C$7.06 – C$12.27 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While the recent price increase may offer a glimmer of hope, investors should remain cautious given the stock's overall downward trend this year and the company’s negative profit margin.
Stock Up 3.03% Today, Still Down 17.64% YTD
Bausch Health's stock remains under pressure, reflecting broader market trends and company-specific challenges despite recent gains.
Bull case
Bausch Health's recent expansion into probiotic skincare markets could help diversify its revenue streams and improve its financial outlook. This move opens up new opportunities for the company to attract customers and boost sales.
Bear case
However, the company faces significant challenges, including a negative profit margin and a moderately bearish outlook from analysts. These factors could hinder any substantial recovery in stock price, making it essential for investors to stay informed and cautious.
Recent Performance
Bausch Health Companies Inc's stock closed at C$8.23, reflecting a daily increase of 3.03% and a weekly gain of 3.68%. Despite this positive movement, the stock has struggled throughout the year, with a year-to-date decline of 17.64%. The stock's performance over the past month has also been negative, down 7.37%. Investors should note that the stock is currently trading within 43% of its 52-week range of C$6.10 to C$11.08.
Advertisement
Company News and Developments
Recent headlines include Bausch Health's expansion into probiotic skincare, which has been rolled out to six new markets as of September 16. This initiative could provide new revenue opportunities for the company. Additionally, the stock has been mentioned in discussions regarding healthcare investments as safe plays amid anticipated Federal Reserve rate hikes.
Technical Picture
The technical indicators for Bausch Health reveal that the stock is currently above its 50-day moving average of C$8.16 by 0.8% and above its 200-day moving average of C$8.06 by 2.2%. The stock has a beta of 0.37, suggesting lower volatility compared to the broader market. However, trading volume has been below average, with the latest volume at 112,681 shares compared to a 20-day average volume of 589,703 shares, indicating a relative decrease in trading activity.
Analyst Outlook
Analysts maintain a moderately bearish outlook on Bausch Health with an average target price of C$7.01, suggesting an implied downside of 14.8% from the current price. Investors may want to consider this perspective when evaluating their positions in the stock.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
